InvestorsHub Logo

sushifishman

02/07/19 1:40 PM

#18193 RE: sab63090 #18192

Sab,
Nice and simple!

I will be looking at the Presentation materials and listening to Geert's presentation on Monday.

I hope he updates the current materials that are posted on their website. These are currently from 11/18.

Page 9 from the 11/19 Corp Presentation
"Enrollment was completed in September 2016. We are currently waiting for 298 events (deaths) in the two main
groups. This is likely to occur in early 2019; it is not possible to accurately predict the timing of events"

Page 27
"The Phase 3 trial was supposed to be a 5 year study, instead it has lasted about 8.5 years so far (lack of enrollment by the former CRO that ran the study from 2011-2013 which essentially caused a restart of the study). We anticipate final results in the first half of 2019, and if successful, Multikine has the potential to become a blockbuster"

There is a big gap between "early 2019" and "final results first half 2019". I believe there was some comments about waiting 2 months after 298 event to ensure data is correct...??